Tumor suppressor p53 and metabolism-Reference-Cited by-同舟云学术

Tumor suppressor p53 and metabolism

Published:2018-11-30 Issue:4 Volume:11 Page:284-292
ISSN:1759-4685
Container-title:Journal of Molecular Cell Biology
language:en
Short-container-title:

Author:

Liu Juan¹,Zhang Cen¹,Hu Wenwei¹²,Feng Zhaohui¹²

Affiliation:

1. Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, State University of New Jersey, New Brunswick, NJ, USA

2. Department of Pharmacology, Rutgers Cancer Institute of New Jersey, Rutgers University, State University of New Jersey, New Brunswick, NJ, USA

Funder

NIH

DoD

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/jmcb/article-pdf/11/4/284/28541804/mjy070.pdf

Reference121 articles.

1. Nucleotide metabolism, oncogene-induced senescence and cancer;Aird;Cancer Lett.,2015

2. Serine and glycine metabolism in cancer;Amelio;Trends Biochem. Sci.,2014

3. ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress;Assaily;Mol. Cell,2011

4. Genetic modifiers of the p53 pathway;Basu;Cold Spring Harb. Perspect. Med.,2016

5. ATP citrate lyase is an important component of cell growth and transformation;Bauer;Oncogene,2005

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calreticulin exposure induced by anticancer drugs is associated with the p53 signaling pathway in colorectal cancer cells;Biochemical and Biophysical Research Communications;2024-11

2. Copper metabolism in osteoarthritis and its relation to oxidative stress and ferroptosis in chondrocytes;Frontiers in Molecular Biosciences;2024-09-11

3. Sex difference in human diseases: mechanistic insights and clinical implications;Signal Transduction and Targeted Therapy;2024-09-10

4. Suppression of neuronal CDK9/p53/VDAC signaling provides bioenergetic support and improves post-stroke neuropsychiatric outcomes;Cellular and Molecular Life Sciences;2024-09-05

5. BH3-mimetics or DNA-damaging agents in combination with RG7388 overcome p53 mutation-induced resistance to MDM2 inhibition;Apoptosis;2024-09-02